Programs Focused on Developing Novel Anti-Inflammatory Drugs, including Scientifically Developed, Non-Psychoactive Cannabinoids that Target Key Pathways in Inflammatory Diseases
PR Newswire
NEW YORK, July 26, 2019
PR Newswire
NEW YORK, July 26, 2019
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey